D.E. Shaw & Co
SLS icon

D.E. Shaw & Co’s SELLAS Life Sciences SLS Stock Holding History

D.E. Shaw & Co’s Portfolio SLS Stock Details SLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-22,086
Closed -$148K – 5779
2022
Q1 		$148K Buy
22,086
+2,943
+15% +$17.2K ﹤0.01% 4939
2021
Q4 		$106K Sell
19,143
-10,778
-36% -$81.5K ﹤0.01% 5052
2021
Q3 		$274K Sell
29,921
-2,193
-7% -$20.3K ﹤0.01% 4410
2021
Q2 		$356K Buy
+32,114
New +$313K ﹤0.01% 4194
2017
Q4 		– Sell
-12
Closed -$6K – 3763
2017
Q3 		$6K Sell
12
-4
-25% -$2.64K ﹤0.01% 3422
2017
Q2 		$14K Buy
+16
New +$13.9K ﹤0.01% 3328
2017
Q1 		– Sell
-123
Closed -$358K – 3616
2016
Q4 		$358K Buy
+123
New +$715K ﹤0.01% 3038

Other funds holding SLS

EAM
Empery Asset Management New York $83M AUM
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.3B AUM 33.54% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
EH
Equitable Holdings New York $15.5B AUM 19.09% 1-Year Est. Return
HCM
Highbridge Capital Management New York $1.58B AUM 31.19% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return